Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
654 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
22 Completed Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
Conditions: Chuvash Polycythemia;   Cerebrovascular Disease;   Pulmonary Hypertension;   Sickle Cell Anemia
Intervention:
23 Recruiting EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat(BAY63-2521)
24 Terminated Safety of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Terbogrel
25 Unknown  Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Conditions: Sarcoidosis;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
26 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo
27 Completed Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: escitalopram
28 Recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
29 Recruiting Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Conditions: Pulmonary Hypertension;   COPD
Intervention: Drug: Inhaled Treprostinil Therapy
30 Unknown  Pulmonary Hypertension, Quality of Life and Psychosocial Factors
Condition: Pulmonary Hypertension
Intervention: Behavioral: Evaluation of quality of life
31 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
32 Completed Pulmonary Hypertension in Lymphangioleiomyomatosis
Conditions: Lymphangioleiomyomatosis;   Pulmonary Hypertension
Intervention:
33 Terminated Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
Condition: Pulmonary Hypertension
Intervention: Drug: Inhaled Iloprost
34 Recruiting Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
Conditions: Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Tadalafil;   Drug: placebo
35 Completed
Has Results
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Pulmonary Hypertension
Intervention: Drug: bosentan
36 Completed Prevalence of Pulmonary Hypertension in COPD Patients
Conditions: COPD;   Pulmonary Hypertension
Intervention:
37 Terminated Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Conditions: Heart Diseases;   Hypertension, Pulmonary
Interventions: Drug: tezosentan;   Drug: placebo
38 Completed Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass Surgery
Condition: Pulmonary Hypertension
Intervention: Drug: aerosolized iloprost
39 Terminated
Has Results
Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease
Conditions: Sickle Cell Disease;   Pulmonary Hypertension
Interventions: Drug: Sildenafil;   Drug: Placebo
40 Completed Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell Anemia
Conditions: Sickle Cell Anemia;   Pulmonary Hypertension
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years